Serotype Distribution of Streptococcus Pneumoniae That Causes Invasive Diseases at Children and Adults in Turkey

Pfizer

Status: Completed

Conditions: Pneumococcal Diseases

Treatments: Other: There is no intervention in this study

Study type: Observational

Funder types: Industry

Identifiers

NCT01810861

B1851148

Details and patient eligibility

About

The aim of this study is to specify the serotype distribution of Streptococcus pneumoniae that causes invasive diseases at children and adults in Turkey.

Full description

Non-interventional observational study Descriptive analysis will be conducted.

Enrollment: 922 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

Serotype distribution and antibiotic sensitivity of pneumococcal isolates that causes invasive pneumococcal diseases which are obtained from the blood, CSF, and/or all other sterile body areas (catheter, pleural fluid, parasynthesis fluid, pericardial fluid, synovial fluid, BAL) of the adults of 18 years of age or older with children that are younger than 18 years old at these centers and laboratories will be defined.

Exclusion criteria

Isolation of any other microorganism than pneumococcus at the same sample.

Trial design

922 participants in 1 patient group

Serotype distribution (this is a non-interventional study)

Description:

Serotype distribution both in pediatrics and adults (this is a non interventional study)

Treatment:

Other: There is no intervention in this study